Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionAqr Capital Management Llc
ManagerCliff Asness
Latest Disclosed Ownership305,412 shares
Latest Disclosed Value $ 9,073,790
Aqr Capital Management Llc reports 13.41% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Aqr Capital Management Llc filed a 13F-HR form disclosing ownership of 305,412 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $9,073,791 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 352,717 shares of Travere Therapeutics, Inc.. This represents a change in shares of -13.41% during the quarter. The current value of the position is $13,804,622 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 305,412 -47,305 -13.41 9,074 -32.68 0.0008
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 352,717 39,340 12.55 13,477 79.96 0.0071
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 313,377 85,284 37.39 7,490 121.90 0.0048
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 228,093 -171,217 -42.88 3,376 -52.83 0.0028
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 399,310 -24,714 -5.83 7,156 -3.13 0.0074
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 424,024 229,361 117.82 7,386 171.24 0.0095
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 194,663 120,594 162.81 2,723 347.86 0.0038
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 74,069 26,485 55.66 609 66.12 0.0009
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 47,584 30,401 176.92 367 137.66 0.0006
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 17,183 -31,068 -64.39 154 -64.27 0.0003
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 48,251 48,251 431 0.0009
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -9,898 -100.00 0 -100.00
2023-05-15 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 9,898 -8,388 -45.87 223 -42.19 0.0005
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 18,286 -12,691 -40.97 385 -49.67 0.0009
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 30,977 6,307 25.57 763 27.59 0.0019
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 24,670 -38,753 -61.10 598 -63.40 0.0014
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 63,423 -11,796 -15.68 1,634 -30.02 0.0031
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 75,219 10,457 16.15 2,335 48.73 0.0042
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 64,762 -15,970 -19.78 1,570 33.28 0.0029
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 80,732 34,931 76.27 1,178 2.97 0.0020
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 45,801 15,944 53.40 1,144 40.54 0.0019
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 29,857 3,058 11.41 814 64.44 0.0014
2020-11-16 2020-09-30 13F RETROPHIN COM 761299106 26,799 -3,125 -10.44 495 -18.99 0.0008
2020-08-17 2020-06-30 13F RETROPHIN COM 761299106 29,924 29,924 611 0.0010
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 0 -22,653 -100.00 0 -100.00
2019-08-14 2019-06-30 13F RETROPHIN COM 761299106 22,653 -10,487 -31.64 455 -39.33 0.0005
2019-05-14 2019-03-31 13F RETROPHIN COM 761299106 33,140 -3,407 -9.32 750 -9.31 0.0008
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 36,547 7,415 25.45 827 -1.19 0.0010
2018-11-15 2018-09-30 13F/A-1 RETROPHIN COM 761299106 29,132 15,740 117.53 837 129.32 0.0008
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 13,392 0 365
2018-08-14 2018-06-30 13F RETROPHIN COM 761299106 13,392 -256 -1.88 365 19.67 0.0004
2018-05-15 2018-03-31 13F RETROPHIN COM 761299106 13,648 -27,158 -66.55 305 -64.53 0.0003
2018-02-14 2017-12-31 13F RETROPHIN COM 761299106 40,806 1,412 3.58 860 -12.33 0.0009
2017-11-14 2017-09-30 13F RETROPHIN COM 761299106 39,394 -8,151 -17.14 981 6.40 0.0012
2017-08-14 2017-06-30 13F RETROPHIN COM 761299106 47,545 -52,135 -52.30 922 -49.89 0.0012
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 99,680 -8,255 -7.65 1,840 -9.98 0.0024
2017-02-14 2016-12-31 13F RETROPHIN COM 761299106 107,935 -12,518 -10.39 2,044 -24.18 0.0028
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 120,453 33,678 38.81 2,696 74.39 0.0041
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 86,775 3,367 4.04 1,546 35.73 0.0027
2016-07-29 2016-03-31 13F/A-1 RETROPHIN COM 761299106 83,408 -20,519 -19.74 1,139 -43.16 0.0020
2016-05-16 2016-03-31 13F RETROPHIN COM 761299106 83,750 1,144
2016-02-16 2015-12-31 13F RETROPHIN COM 761299106 103,927 -14,432 -12.19 2,004 -16.43 0.0035
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 118,359 -25,276 -17.60 2,398 -49.64 0.0048
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 143,635 93,735 187.85 4,762 298.16 0.0094
2015-05-15 2015-03-31 13F RETROPHIN COM 761299106 49,900 9,300 22.91 1,196 140.64 0.0027
2015-04-22 2014-12-31 13F/A-1 RETROPHIN COM 761299106 40,600 2,100 5.45 497 43.23 0.0010
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 40,600 497
2014-11-14 2014-09-30 13F RETROPHIN COM 761299106 38,500 38,500 347 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.